47.73.Z - Retail sale of pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
2022 | 2023 | ||
---|---|---|---|
M PLN | M PLN | % | |
Assets | 1,2 | 1,8 | 48,6 |
Profit (loss) on sale | -0 | 0,2 | 846,7 |
Gross profit (loss) | -0 | 0,3 | 731,7 |
Net profit (loss) | -0 | 0,3 | 731,7 |
Cash | 0,3 | 0,4 | 36,4 |
Liabilities and provisions for liabilities | 1,1 | 1,4 | 32,5 |
Net income from sale | 0,9 | 4,3 | 378,8 |
Short time liabilities | 1,1 | 1,4 | 32,5 |
Other operating costs | 0 | 0 | -∞ |
Working assets | 0,9 | 1,6 | 68,1 |
Equity capital | 0,2 | 0,4 | 157,2 |
Other income costs | 0 | 0 | 7791,6 |
Operating profit (EBIT) | -0 | 0,2 | 917,1 |
% | % | p.p. | |
Profitability of capital | -24,9 | 61,1 | 86 |
Equity capital to total assets | 12,9 | 22,3 | 9,4 |
Gross profit margin | -4,4 | 5,9 | 10,3 |
Days | Days | Days | |
Short term commitment turnover cycle | 440 | 122 | -318 |
Current financial liquidity indicator | 0.8592990636825562 | 1.090261459350586 | 0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane